{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:22:56Z","timestamp":1790130176016,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,25]],"date-time":"2014-01-25T00:00:00Z","timestamp":1390608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s12519-014-0453-5","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T01:02:54Z","timestamp":1390525374000},"page":"59-63","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai"],"prefix":"10.1007","volume":"10","author":[{"given":"Li","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,25]]},"reference":[{"key":"453_CR1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00467-010-1717-5","volume":"26","author":"M Husen van","year":"2011","unstructured":"van Husen M, Kemper MJ. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol 2011;26:881\u2013892.","journal-title":"Pediatr Nephrol"},{"key":"453_CR2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.ajkd.2007.02.270","volume":"49","author":"HA Kyrieleis","year":"2007","unstructured":"Kyrieleis HA, Levtchenko EN, Wetzels JF. Long-term outcome after cyclophosphamide treatment in children with steroiddependent and frequently relapsing minimal change nephrotic syndrome. Am J Kidney Dis 2007;49:592\u2013597.","journal-title":"Am J Kidney Dis"},{"key":"453_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ndt\/18.2.245","volume":"18","author":"P Grimbert","year":"2003","unstructured":"Grimbert P, Audard V, Remy P, Lang P, Sahali D. Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant 2003;18:245\u2013248.","journal-title":"Nephrol Dial Transplant"},{"key":"453_CR4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00467-004-1434-z","volume":"19","author":"K Benz","year":"2004","unstructured":"Benz K, D\u00f6tsch J, Rascher W, Stachel D. Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 2004;19:794\u2013797.","journal-title":"Pediatr Nephrol"},{"key":"453_CR5","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00467-006-0228-x","volume":"21","author":"RD Gilbert","year":"2006","unstructured":"Gilbert RD, Hulse E, Rigden S. Rituximab therapy for steroiddependent minimal change nephrotic syndrome. Pediatr Nephrol 2006;21:1698\u20131700.","journal-title":"Pediatr Nephrol"},{"key":"453_CR6","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMc055495","volume":"354","author":"MD Pescovitz","year":"2006","unstructured":"Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006;354:1961\u20131963.","journal-title":"N Engl J Med"},{"key":"453_CR7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00467-006-0427-5","volume":"22","author":"GC Smith","year":"2007","unstructured":"Smith GC. Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Pediatr Nephrol 2007;22:893\u2013898.","journal-title":"Pediatr Nephrol"},{"key":"453_CR8","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1056\/NEJMc063706","volume":"356","author":"A Bagga","year":"2007","unstructured":"Bagga A, Sinha A, Moudgil A. Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 2007;356:2751\u20132752.","journal-title":"N Engl J Med"},{"key":"453_CR9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","volume":"23","author":"V Guigonis","year":"2008","unstructured":"Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, et al. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 2008;23:1269\u20131279.","journal-title":"Pediatr Nephrol"},{"key":"453_CR10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","volume":"24","author":"K Kamei","year":"2009","unstructured":"Kamei K, Ito S, Nozu K, Fujinaga S, Nakayama M, Sako M, et al. Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol 2009;24:1321\u20131328.","journal-title":"Pediatr Nephrol"},{"key":"453_CR11","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00467-011-1886-x","volume":"26","author":"S Ito","year":"2011","unstructured":"Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, et al. Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 2011;26:1823\u20131828.","journal-title":"Pediatr Nephrol"},{"key":"453_CR12","first-page":"482","volume":"24","author":"GL Liu","year":"2011","unstructured":"Liu GL, Mao S, Xia ZK, Fan ZM, Ren XG, He X, et al. Rituximab for steroid-dependentnephrotic syndrome in children. Yi Xue Yan Jiu Sheng Xue Bao 2011;24:482\u2013484. [In Chinese]","journal-title":"Yi Xue Yan Jiu Sheng Xue Bao"},{"key":"453_CR13","first-page":"1","volume":"16","author":"N Guan","year":"2010","unstructured":"Guan N, Ding J. Anti-CD20 monoclonal antibody in treatment of refractory nephrotic syndrome. Er Ke Yao Xue Za Zhi 2010;16:1\u20133. [In Chinese]","journal-title":"Er Ke Yao Xue Za Zhi"},{"key":"453_CR14","first-page":"167","volume":"47","author":"The Subspecialty Group of Nephrology, Society of Pediatrics, Chinese Medical Association.","year":"2009","unstructured":"The Subspecialty Group of Nephrology, Society of Pediatrics, Chinese Medical Association. Evidence-based guidelines on diagnosis and treatment of childhood common renal disease (I): Guideline on diagnosis and treatment of steroid-sensitive, relapsing\/steroid-dependent nephrotic syndrome. Zhonghua Er Ke Za Zhi 2009;47:167\u2013170. [In Chinese]","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"453_CR15","first-page":"72","volume":"48","author":"The Subspecialty Group of Nephrology, Society of Pediatrics, Chinese Medical Association.","year":"2010","unstructured":"The Subspecialty Group of Nephrology, Society of Pediatrics, Chinese Medical Association. Evidence-based guidelines on diagnosis and treatment of childhood common renal diseases (III): Guideline on diagnosis and treatment of steroid-resistant nephrotic syndrome. Zhonghua Er Ke Za Zhi 2010;48:72\u201375.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"453_CR16","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","volume":"5","author":"A Gulati","year":"2010","unstructured":"Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, et al. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 2010;5:2207\u20132212.","journal-title":"Clin J Am Soc Nephrol"},{"key":"453_CR17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00467-009-1376-6","volume":"25","author":"A Prytu\u0142a","year":"2010","unstructured":"Prytu\u0142a A, Iijima K, Kamei K, Geary D, Gottlich E, Majeed A, et al. Rituximab in refractory nephrotic syndrome. Pediatr Nephrol 2010;25:461\u2013468.","journal-title":"Pediatr Nephrol"},{"key":"453_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00467-007-0640-x","volume":"23","author":"M Nakayama","year":"2008","unstructured":"Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, et al. Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol 2008;23:481\u2013485.","journal-title":"Pediatr Nephrol"},{"key":"453_CR19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00467-011-1778-0","volume":"26","author":"JA Kari","year":"2011","unstructured":"Kari JA, El-Morshedy SM, El-Desoky S, Alshaya HO, Rahim KA, Edrees BM. Rituximab for refractory cases of childhood nephrotic syndrome. Pediatr Nephrol 2011;26:733\u2013737.","journal-title":"Pediatr Nephrol"},{"key":"453_CR20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00467-010-1465-6","volume":"25","author":"AL Sellier-Leclerc","year":"2010","unstructured":"Sellier-Leclerc AL, Macher MA, Loirat C, Gu\u00e9rin V, Watier H, Peuchmaur M, et al. Rituximab efficiency in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 2010;25:1109\u20131115.","journal-title":"Pediatr Nephrol"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-014-0453-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-014-0453-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-014-0453-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T13:03:25Z","timestamp":1559567005000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-014-0453-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,25]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1007\/s12519-014-0453-5","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,25]]}}}